Abstract
Several authors have reported that Gemfibrozil decreases the plasma concentration of triglycerides (TG) and (to a lesser extent) cholesterol (CT) and raises HDL in hyperlipoproteinemias (Olsson et al. 1976; Manninen 1983; Pickering 1983; Samuel 1984).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Kesäniemi YA, Grundy SM (1984) Influence of Gemfibrozil and Clofibrate on metabolism of cholesterol and plasma triglycerides in man. JAMA 251: 2241–2246
Krause BR, Newton RS (1985) Apolipoprotein changes associated with the plasma lipid-regulating activity of Gemfibrozil in cholesterol-fed rats. J Lipid Res 26: 940–949
Manninen V (1983) Clinical results with Gemfibrozil and background to the Helsinki heart study. Am J Cardiol 52: 35B-38B
Manzato E, Marin R, Gasparotto A, Baggio G, Martini S, Gabelli C, Crepaldi G (1986) Lipoprotein modification during dietary treatment in patients with primary type V hyperlipoproteinemia. Eur J Clin Invest 16: 149–156
Martini S, Baggio G, Baroni L, Baldo Enzi G, Fellin R, Baiocchi MR, Crepaldi G (1984) Evaluation of HDL2 and HDL3 cholesterol by a precipitation procedure in a normal population and in different hyperlipidemic phenotypes. Clin Chim Acta 137: 291–298
Olsson AG, Rössner S, Walldius G, Carlson LA (1976) Effect of Gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinemia. Proc R Soc Med 69: 28–31
Pickering JE (1983) Clinical results with Gemfibrozil. Am J Cardiol 52: 39B-40B
Saku K, Gartside PS, Hynd BA, Kashyap ML (1985) Mechanism of action of Gemfibrozil on lipoprotein metabolism. J Clin Invest 75: 1702–1712
Samuel P (1984) Efficacy of Gemfibrozil as a lipid regulator in a patient population in the United States. Vasc Med 2: 8–15
Vega GL, Grundy SM (1985) Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. JAMA 253: 2398–2403
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Manzato, E., Zambon, S., Marin, R., Baggio, G., Crepaldi, G. (1987). Plasma Lipids, Lipoproteins, and Apoproteins During Gemfibrozil Treatment in Primary Hyperlipidemias. In: Paoletti, R., Kritchevsky, D., Holmes, W.L. (eds) Drugs Affecting Lipid Metabolism. Proceedings in Life Sciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71702-4_66
Download citation
DOI: https://doi.org/10.1007/978-3-642-71702-4_66
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71704-8
Online ISBN: 978-3-642-71702-4
eBook Packages: Springer Book Archive